Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
MgLPkeQ0eP0XHDba
Français